Post Cycle Therapy (PCT): The Complete Guide to Recovery

Post Cycle Therapy (PCT) is the pharmacological protocol used to restore natural testosterone production after suppression by exogenous androgens — anabolic steroids, SARMs, or any compound that shuts down the Hypothalamic-Pituitary-Testicular Axis (HPTA). Without PCT, natural testosterone recovery can take 6-12 months (sometimes longer), leaving you in a hypogonadal state characterized by muscle loss, fat gain, depression, low libido, and hormonal dysfunction.

The HPTA operates on a negative feedback loop: when exogenous androgens flood the bloodstream, the hypothalamus detects supraphysiological androgen/estrogen levels and stops producing GnRH (Gonadotropin-Releasing Hormone). Without GnRH, the pituitary stops producing LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone). Without LH and FSH, the testes stop producing testosterone and sperm. This cascade represents complete HPTA suppression — and it is what every steroid cycle produces.

PCT reverses this shutdown using compounds that either block estrogen at the hypothalamus (SERMs), reduce circulating estrogen (AIs), or directly stimulate testicular function (HCG). The goal is clear: restart endogenous testosterone production as quickly and completely as possible to preserve the muscle gained on cycle while restoring hormonal health.

This guide covers every PCT compound, protocol, and scenario — from mild SARM recoveries to heavy 19-nor blast rehabilitations.

[Internal Link: /blog/pct-beginners-guide/]

---

Why PCT Is Necessary

The HPTA Suppression Cascade

1. Exogenous androgens enter bloodstream (injected testosterone, oral steroids, SARMs)
2. Hypothalamus detects elevated sex hormones (both androgens and estrogen from aromatization)
3. Hypothalamus reduces/stops GnRH secretion (negative feedback)
4. Pituitary reduces/stops LH and FSH production (no GnRH signal)
5. Testes reduce/stop testosterone and sperm production (no LH/FSH signal)
6. Testicular atrophy begins (unused Leydig cells shrink within 2-4 weeks)

When exogenous androgens are discontinued, the system must restart in reverse order: hypothalamus → pituitary → testes. But there is a problem: estrogen is the primary suppressive signal at the hypothalamus. When testosterone drops (cycle ends), the remaining estrogen — from aromatization of residual compounds and from adipose tissue — continues suppressing the hypothalamus. This is why estrogen management is the core of PCT.

What Happens Without PCT

Without pharmacological intervention after a suppressive cycle:

• Testosterone may remain at hypogonadal levels (sub-300 ng/dL) for 3-12+ months
• Muscle loss accelerates in the catabolic low-testosterone environment
• Fat gain occurs (testosterone is the primary anti-lipogenic signal in males)
• Mood deterioration, depression, and cognitive fog from hormonal deficiency
• Sexual dysfunction (low libido, erectile dysfunction, anorgasmia)
• Potential permanent HPTA damage if shutdown was prolonged and recovery is not assisted

---

PCT Compounds

SERMs (Selective Estrogen Receptor Modulators)

SERMs are the backbone of PCT. They block estrogen receptors at the hypothalamus and pituitary — tricking these glands into thinking estrogen is low — which triggers compensatory GnRH, LH, and FSH production. Critically, SERMs are selective: they block estrogen in some tissues while activating it in others (bone, liver/lipids).

Nolvadex (Tamoxifen Citrate)

Nolvadex is the gold standard PCT SERM. It blocks estrogen receptors in the hypothalamus and pituitary, directly stimulating LH and FSH production. Clinical studies demonstrate tamoxifen elevates testosterone 150-200% above suppressed baseline within 2-4 weeks. It also blocks estrogen at breast tissue (preventing/treating gynecomastia) while acting as an estrogen agonist in bone (protective) and liver (improves lipid profile).

PCT dosing: 20mg/day for 4-6 weeks (standard). Some protocols use 40mg/day week 1-2, then 20mg/day weeks 3-4 (frontloaded approach).

Mechanism: Competitive estrogen receptor antagonist at hypothalamus → GnRH release → LH/FSH → testicular testosterone production.

Side effects: Rare at PCT doses — occasional emotional blunting, visual disturbances (extremely rare, reversible), headache.

[Internal Link: /blog/nolvadex-tamoxifen-pct-guide/] [Internal Link: /product/nolvadex/]

Clomid (Clomiphene Citrate)

Clomid is a mixed estrogen agonist/antagonist that stimulates the hypothalamic-pituitary axis. It is more potent than Nolvadex at stimulating LH/FSH per milligram but carries more side effects. Clomid is the standard fertility-restoration drug prescribed by endocrinologists for hypogonadal men. Its dual mechanism (both blocking and stimulating estrogen receptors depending on tissue) makes its action more complex than Nolvadex.

PCT dosing: 50mg/day for 4 weeks (standard). Some protocols use 100mg/day week 1, then 50mg/day weeks 2-4. Avoid exceeding 100mg/day — diminishing returns with increased side effects.

Mechanism: Mixed agonist/antagonist — blocks estrogen at hypothalamus while mildly stimulating estrogen receptors elsewhere. Net effect: robust LH/FSH elevation.

Side effects: More common than Nolvadex — emotional volatility, vision changes (phosphenes, blurred vision), headaches, possible depression at high doses.

[Internal Link: /blog/clomid-clomiphene-pct-guide/] [Internal Link: /product/clomid/]

Raloxifene

Raloxifene is a second-generation SERM with higher selectivity than tamoxifen. It blocks estrogen at breast tissue (superior to Nolvadex for gynecomastia reversal) and stimulates estrogen in bone. At the hypothalamus, raloxifene's antagonism is weaker than Nolvadex — making it a secondary PCT choice. Its primary role is gynecomastia management (both prevention and reversal of existing tissue) rather than primary HPTA stimulation.

PCT dosing: 60mg/day (typically paired with Nolvadex rather than standalone for PCT). For gynecomastia specifically: 60mg/day for 3-6 months.

Mechanism: Selective estrogen antagonist — strongest at breast tissue ER, moderate at hypothalamic ER.

Side effects: Minimal — rare leg cramps, very low DVT risk (lower than tamoxifen).

[Internal Link: /blog/raloxifene-gynecomastia-guide/] [Internal Link: /product/raloxifene/]

---

Aromatase Inhibitors (AIs)

AIs reduce circulating estrogen by blocking the aromatase enzyme (which converts testosterone to estrogen). In PCT, they serve a specific role: preventing estrogen rebound during the early recovery phase when testosterone is rising and potentially aromatizing before the HPTA has fully recovered. AIs are NOT primary PCT drugs — they do not stimulate LH/FSH. They support SERM therapy by keeping estrogen from re-suppressing the recovering axis.

Arimidex (Anastrozole)

Arimidex is a reversible aromatase inhibitor that reduces estrogen by approximately 50-70% at standard doses. In PCT context, it prevents estrogen rebound that can occur when testosterone begins recovering (more testosterone = more substrate for aromatization). Use only if estrogen symptoms emerge during PCT (nipple sensitivity, water retention, mood instability).

PCT dosing: 0.5mg every other day OR only as needed (when estrogen symptoms appear). Do NOT crash estrogen during PCT — low estrogen impairs recovery as much as high estrogen.

On-cycle dosing: 0.5mg EOD (or as needed per blood work, targeting estradiol 20-30 pg/mL)

[Internal Link: /blog/arimidex-anastrozole-guide/] [Internal Link: /product/arimidex/]

Aromasin (Exemestane)

Aromasin is a suicidal (irreversible) aromatase inhibitor — it permanently deactivates aromatase enzymes it binds. This eliminates estrogen rebound when discontinued (unlike Arimidex, where estrogen rebounds as the drug clears). Aromasin also mildly stimulates testosterone production itself and does not negatively impact lipids like Arimidex. These properties make it the preferred AI during PCT when an AI is needed.

PCT dosing: 12.5mg every other day (or 25mg every other day for aggressive estrogen control). Less is more — only use if estrogen symptoms present during SERM therapy.

Advantage over Arimidex in PCT: No rebound, mild androgenic/anabolic activity, lipid-neutral.

[Internal Link: /blog/aromasin-exemestane-guide/] [Internal Link: /product/aromasin/]

Letrozole (Femara)

Letrozole is the most potent AI — reducing estrogen by up to 98%. In PCT, it is reserved for emergency estrogen management (severe gynecomastia flare, extreme estrogen rebound). It should NOT be used routinely in PCT because crashing estrogen to near-zero impairs LH release (the hypothalamus needs some estrogen to function normally), destroys joints, tanks libido, and crashes mood.

PCT dosing: 0.25-0.5mg only for acute gynecomastia management. NOT a maintenance PCT drug.

On-cycle emergency: 2.5mg/day for 3-5 days to rapidly crush estrogen during acute gyno flare, then taper.

[Internal Link: /blog/letrozole-femara-guide/] [Internal Link: /product/letrozole/]

---

HCG (Human Chorionic Gonadotropin)

HCG mimics LH at the testes — directly stimulating Leydig cells to produce testosterone. It bypasses the hypothalamus and pituitary entirely, working from the bottom up. HCG's role in PCT is testicular priming: restarting testicular function and reversing atrophy BEFORE SERMs take over the job of restarting the full axis from the top down.

Critical distinction: HCG is used BEFORE or during the transition TO PCT — not as PCT itself. Chronic HCG use without SERMs actually suppresses the hypothalamus (HCG-driven testosterone production creates negative feedback). The correct sequence: HCG primes the testes → SERMs restart the hypothalamus/pituitary → then discontinue HCG.

Pre-PCT priming protocol: 1500-2000 IU every other day for 2 weeks, starting when the last compound begins clearing. Then discontinue HCG and begin SERMs 3-5 days later.

On-cycle (prevention): 250-500 IU twice weekly throughout cycle prevents testicular atrophy entirely, making PCT faster and more complete. This is the optimal approach — it is easier to maintain function than to restore it.

[Internal Link: /blog/hcg-pct-protocol-guide/] [Internal Link: /product/hcg/]

---

Triptorelin

Triptorelin is a GnRH agonist that, in a single 100mcg dose, can trigger an LH/FSH surge that restarts the entire HPTA. This is sometimes called "the nuclear PCT option." The mechanism: a single GnRH pulse desensitizes the negative feedback temporarily, producing a massive gonadotropin release that jumpstarts the testes.

Warning: Triptorelin is dose-critical. A single 100mcg dose (once, not repeated) is the protocol. Continuous or repeated dosing causes the opposite effect — complete GnRH receptor desensitization and chemical castration (the basis of prostate cancer treatment). This compound demands precision and is not recommended for inexperienced users.

Use case: Last-resort recovery from extremely prolonged (1+ year) or heavy 19-nor cycles where standard SERM PCT has failed to restore testosterone. Not a first-line or routine PCT drug.

[Internal Link: /blog/triptorelin-gnrh-pct-guide/] [Internal Link: /product/triptorelin/]

---

PCT Protocols by Cycle Type

Protocol 1: SARMs-Only Cycle (Mild Suppression)

Applicable to: Ostarine, LGD-4033, RAD-140 (8 weeks or less), ACP-105

Timing: Start PCT the day after last SARM dose (SARMs have short half-lives, no waiting period)

Protocol:

• Nolvadex 20mg/day for 4 weeks

OR (minimal suppression — Ostarine under 8 weeks):

• No PCT; natural recovery in 2-4 weeks (monitor with blood work)

No HCG needed — testicular atrophy is minimal with SARMs.

[Internal Link: /blog/sarms-pct-protocol/]

Protocol 2: Testosterone-Only Cycle

Applicable to: Testosterone Enanthate/Cypionate 300-500mg/week, 12-16 weeks

Timing: Start PCT 2 weeks after last injection (allows ester clearance — Enanthate half-life is 4.5 days, need ~2 weeks for levels to drop)

Protocol:

• Optional HCG primer: 1500 IU EOD for 10 days starting at week 14 (while test is clearing)
• Nolvadex 20mg/day for 6 weeks, starting after HCG completion (or 2 weeks after last injection if no HCG)
• Alternative: Nolvadex 40/40/20/20mg (4 weeks, frontloaded)

[Internal Link: /blog/testosterone-only-pct-protocol/]

Protocol 3: Multi-Compound Cycle (No 19-Nors)

Applicable to: Testosterone + Masteron, Testosterone + Anavar, Testosterone + Equipoise, etc.

Timing: 2 weeks after last long-ester injection. If Equipoise was used, wait 3-4 weeks (EQ's Undecylenate ester has a 14-day half-life).

Protocol:

• HCG 1500 IU EOD for 2 weeks (starting when esters are clearing)
• Then: Nolvadex 20mg/day + Aromasin 12.5mg EOD for 6 weeks
• Aromasin tapered off after week 4 if estrogen is controlled

Protocol 4: 19-Nor Cycle (Deca/Tren/MENT)

Applicable to: Any cycle containing Nandrolone (Deca, NPP) or Trenbolone

Critical note: 19-Nor metabolites (19-norandrosterone for Nandrolone, various for Trenbolone) remain suppressive for MONTHS after the parent compound clears. Nandrolone Decanoate metabolites suppress the HPTA for up to 18 months post-injection. This means standard 4-6 week PCT is often insufficient.

Timing:

• NPP/Tren Ace: Start 3-4 days after last injection
• Deca/Tren E: Start 3-4 weeks after last injection
• Continue testosterone at TRT dose (100-150mg/week) for 2-3 weeks after dropping the 19-nor to maintain androgen levels while it clears

Protocol (extended):

• HCG 1500 IU EOD for 3 weeks
• Then: Nolvadex 20mg/day for 8 weeks (extended duration)
• Clomid 50mg/day may be added for weeks 1-4 alongside Nolvadex for dual SERM stimulation
• Aromasin 12.5mg EOD weeks 1-4 (prevent estrogen rebound)

Alternative for Deca specifically: Continue TRT-dose testosterone for 4-6 weeks after last Deca injection (bridging while metabolites clear), then standard testosterone PCT.

[Internal Link: /blog/19-nor-pct-protocol-deca-tren/]

Protocol 5: Blast and Cruise Recovery (Returning to Natural)

Applicable to: Users who have been on continuous testosterone (cruise doses between blasts) for 6+ months and want to come off completely.

This is the hardest recovery scenario. The HPTA has been suppressed for an extended period. Testicular atrophy is significant. Pituitary sensitivity may be reduced.

Protocol:

• Reduce to TRT dose (100mg/week) for 4 weeks minimum before starting PCT
• HCG 2000 IU EOD for 3-4 weeks (aggressive testicular priming — testes need rehabilitation)
• Then: Nolvadex 20mg/day for 8-12 weeks
• Clomid 25-50mg/day for first 4-6 weeks alongside Nolvadex
• Blood work at weeks 4, 8, and 12 post-PCT start

Realistic expectations: Full recovery from blast-and-cruise may take 6-12 months. Some users never fully recover to pre-use testosterone levels, particularly if they were on for 2+ years or are over 35. If testosterone remains below 400 ng/dL after 6 months of recovery, TRT may be the pragmatic long-term option.

[Internal Link: /blog/blast-cruise-recovery-pct/]

---

Timing Guide: When to Start PCT

The principle is simple: PCT begins when exogenous compounds have cleared to the point where they are no longer significantly suppressing the HPTA. Starting too early (compounds still active) means SERMs fight against ongoing suppression — wasting the PCT window.

---

Bloodwork During and After PCT

Pre-PCT Blood Work (Baseline While Suppressed)

Draw immediately before starting PCT to establish suppressed baseline:

• Total Testosterone, Free Testosterone
• LH, FSH
• Estradiol (sensitive)
• SHBG
• CBC (hematocrit reference)
• Prolactin (if 19-nors were used)

Mid-PCT Blood Work (Week 3-4)

Confirms PCT compounds are working:

• LH and FSH should be rising (target: at least above reference range minimum)
• Testosterone should be recovering (target: above 300 ng/dL minimum)
• Estradiol should be within range (20-40 pg/mL — not crashed, not elevated)

Post-PCT Blood Work (4-6 Weeks After PCT Completion)

The critical test — confirms sustainable natural production without pharmaceutical support:

• Total Testosterone (target: 400+ ng/dL minimum, ideally 500+)
• Free Testosterone (target: within reference range)
• LH, FSH (should be within range — elevated LH with low T suggests primary hypogonadism)
• Estradiol (should normalize without AI support)

Red flag: LH/FSH are elevated but testosterone remains low → primary testicular failure (testes are not responding to stimulation). May indicate permanent Leydig cell damage from prolonged suppression. TRT evaluation warranted.

Red flag: LH/FSH remain low AND testosterone is low → secondary hypogonadism (pituitary still suppressed). May require extended SERM therapy or re-evaluation of recovery timeline.

[Internal Link: /blog/pct-bloodwork-interpretation/]

---

Recovery Timeline Expectations

SARMs-Only (Mild)

• PCT duration: 4 weeks
• Natural recovery: 2-6 weeks post-PCT
• Full hormonal normalization: 1-2 months total

Standard Testosterone Cycle (12-16 weeks)

• PCT duration: 6 weeks
• Natural recovery: 4-8 weeks post-PCT
• Full hormonal normalization: 3-4 months total

Multi-Compound / 19-Nor Cycle

• PCT duration: 8-12 weeks
• Natural recovery: 2-6 months post-PCT
• Full hormonal normalization: 6-12 months total (19-nor metabolites linger)

Extended Blast-and-Cruise (1+ year on)

• PCT duration: 8-12 weeks
• Natural recovery: 3-12 months post-PCT
• Full hormonal normalization: 6-18 months (some never fully recover)

Important: These timelines assume proper PCT execution. Skipping PCT or using inadequate protocols doubles recovery time at minimum.

---

Common PCT Mistakes

Mistake 1: Starting PCT Too Early

If exogenous compounds are still active in your bloodstream when you begin SERMs, the ongoing suppression overwhelms the SERM's stimulatory effect. You waste your PCT window fighting against residual androgens. Always respect the clearance timeline based on compound half-lives — PCT begins when levels have dropped to near-baseline, not the day after your last injection.

Mistake 2: Starting PCT Too Late

The opposite error: waiting too long after compounds clear. Without both exogenous androgens AND natural production, you exist in a hypogonadal wasteland — losing muscle rapidly, accumulating fat, and suffering mood/libido consequences. The ideal is to begin PCT within the window where compounds have cleared but natural production has not yet restarted on its own (which would be slow and incomplete without intervention).

Mistake 3: Insufficient Duration

Four weeks of Nolvadex is the minimum for the mildest suppression (short SARM cycles). Most testosterone cycles need 6 weeks. 19-nor cycles need 8-12 weeks. Cutting PCT short because "I feel fine at week 3" is premature — LH/FSH may be rising but sustainable natural production has not yet been confirmed. Complete the full protocol regardless of subjective wellbeing.

Mistake 4: Using AI as Primary PCT

Aromatase inhibitors do not stimulate LH or FSH. They only manage estrogen. Using Arimidex or Aromasin alone as "PCT" does nothing to restart the HPTA — it merely suppresses estrogen, which if taken too aggressively, actually IMPAIRS recovery (the hypothalamus needs some estrogen signal to function). AIs are supporting players, not leads.

Mistake 5: Crashing Estrogen

The most common PCT error. Running aggressive AI dosing alongside SERMs drives estrogen to near-zero. The symptoms: destroyed joints, zero libido, severe depression, cognitive fog, insomnia, and paradoxically — impaired testosterone recovery. The hypothalamus uses estrogen as a positive feedback signal at low levels. Crashed estrogen = no feedback signal = no GnRH. Let estrogen exist in the normal range during PCT.

Mistake 6: Ignoring Blood Work

"I feel recovered" is not the same as being recovered. Testosterone can be at 250 ng/dL (clearly hypogonadal) while someone subjectively feels "okay" because they've adapted to their suppressed state. Blood work at the 4-6 week post-PCT mark is the ONLY way to confirm genuine recovery. Without it, you are guessing.

---

When PCT Fails: The TRT Consideration

PCT failure is defined as: testosterone remaining below 300-400 ng/dL with symptoms of hypogonadism 6+ months after cycle completion with proper PCT execution.

Factors increasing PCT failure risk:

• Age over 35 (natural decline compounds recovery difficulty)
• Prolonged suppression (2+ years continuous)
• Heavy 19-nor use (metabolite-mediated suppression lingers)
• Multiple heavy cycles without adequate time off
• Pre-existing borderline testosterone (started cycling from already-low baseline)
• Genetic predisposition to poor HPTA resilience

If PCT fails, the options are:

1. Extended SERM therapy — Nolvadex or Clomid for 3-6 months (some endocrinologists prescribe this)
2. Enclomiphene — Pure isomer of Clomid without the estrogenic zuclomiphene; may sustain LH/FSH long-term
3. TRT (Testosterone Replacement Therapy) — Accept permanent exogenous replacement at physiological doses (100-200mg/week). This means lifelong injections but eliminates the suffering of hypogonadism.

TRT is not failure — it is a pragmatic medical decision. Many users who cycle for years eventually transition to TRT by choice, not necessity. The important thing is making an informed decision based on blood work, not assumptions.

[Internal Link: /blog/when-pct-fails-trt-decision/]

---

Frequently Asked Questions

Can I skip PCT after a short cycle?

Potentially — if the cycle was truly short (4-6 weeks) and low dose (under 300mg testosterone/week or a mild SARM). Draw blood 4 weeks after your last dose. If LH, FSH, and testosterone are within range, you recovered naturally. If suppressed, start PCT immediately. Having Nolvadex on hand before any cycle is non-negotiable — you need the option available even if you hope not to use it.

Should I use Clomid or Nolvadex?

Nolvadex is preferred for most situations. It produces reliable LH/FSH stimulation with fewer side effects than Clomid. Clomid is more potent at gonadotropin stimulation but causes emotional instability, vision disturbances, and depression in a meaningful percentage of users. Use Nolvadex as default. Add Clomid for stubborn cases (19-nor recovery, extended suppression) where maximum stimulation is needed.

Do SARMs really require PCT?

Depends on the SARM and cycle length. Ostarine 8 weeks at 15mg — most users recover without PCT in 2-3 weeks. RAD-140 12 weeks at 20mg — yes, PCT is needed (testosterone will be significantly suppressed). LGD-4033 8+ weeks at 10mg — yes, PCT recommended. Rule of thumb: if a blood draw shows LH below 3 mIU/mL and testosterone below 300 ng/dL, run PCT regardless of what you took.

Can I use HCG alone as PCT?

No. HCG alone keeps the testes producing testosterone BUT it suppresses the hypothalamus/pituitary through negative feedback (the testosterone HCG produces feeds back and suppresses GnRH). When you stop HCG without SERM support, you crash again. HCG is a PRIMING tool that feeds into SERM-based PCT — never a standalone recovery protocol.

How do I manage estrogen during PCT?

The golden rule: do NOT crash estrogen during PCT. The hypothalamus needs some estrogen to function normally. If estrogen symptoms appear during PCT (gyno tenderness, excessive water retention): add Aromasin 12.5mg EOD. If no symptoms: do not use an AI. Crashed estrogen during PCT causes: joint pain, zero libido, depression, impaired recovery — the opposite of what you need.

What about Enclomiphene for PCT?

Enclomiphene is the trans-isomer of clomiphene (Clomid contains both enclomiphene and zuclomiphene). It provides pure HPTA stimulation without zuclomiphene's estrogenic side effects. Research demonstrates sustained testosterone elevation during chronic use. It is emerging as a potential long-term alternative to TRT for secondary hypogonadism — maintaining natural production while supplementing the pituitary signal. Currently available from research chemical sources in Canada.

[Internal Link: /blog/enclomiphene-pct-alternative/]

When should I get blood work after PCT?

Wait a minimum of 4 weeks after completing all PCT drugs before drawing blood. SERMs (especially Clomid) can artificially inflate LH/FSH/testosterone readings for several weeks after discontinuation. You need to confirm your endogenous production sustains WITHOUT pharmacological support. The 4-6 week post-PCT draw reflects your actual recovered hormonal state.

---

Conclusion

PCT is not optional after suppressive cycles — it is the difference between recovering your hormonal health in weeks versus months (or never). The compounds are accessible, the protocols are well-established, and the blood work to monitor recovery is straightforward.

The hierarchy is clear: HCG primes the testes → SERMs restart the hypothalamus/pituitary → AIs manage estrogen only if needed → blood work confirms recovery. Match protocol aggressiveness to suppression severity, and always have PCT compounds in hand before beginning any cycle.

Your natural hormonal system is remarkably resilient when supported properly. Give it the pharmacological tools and the time it needs.

[Internal Link: /blog/pct-beginners-guide/] [Internal Link: /blog/nolvadex-tamoxifen-pct-guide/] [Internal Link: /blog/hcg-pct-protocol-guide/] [Internal Link: /blog/19-nor-pct-protocol-deca-tren/] [Internal Link: /blog/pct-bloodwork-interpretation/] [Internal Link: /blog/when-pct-fails-trt-decision/]